Disinhibition augments thirst perception from two dehydrating stimuli in men.


Journal

Appetite
ISSN: 1095-8304
Titre abrégé: Appetite
Pays: England
ID NLM: 8006808

Informations de publication

Date de publication:
01 Mar 2023
Historique:
received: 25 10 2022
revised: 15 12 2022
accepted: 16 12 2022
pmc-release: 01 03 2024
pubmed: 21 12 2022
medline: 26 1 2023
entrez: 20 12 2022
Statut: ppublish

Résumé

Physiological systems controlling water and energy ingestion are coordinated. Whether maladaptive eating behavior and appetite for water are linked is unknown. Thus, we sought to investigate the association between maladaptive eating and both thirst and water drinking behavior with two dehydrating conditions. Twenty-two lean men and 20 men with obesity (mean age 32.3 ± 8.4 years and 30.0 ± 11.1 years, respectively) completed the Three-Factor Eating Questionnaire (TFEQ) and Gormally Binge Eating Scale. On separate days, volunteers were dehydrated by a 2-h hypertonic saline infusion and a 24-h water deprivation, and thirst was measured on a 100-mm visual analogue scale (VAS) during each procedure. After each dehydrating condition, ad libitum water intake was measured. In the saline infusion, higher Disinhibition on the TFEQ was associated with thirst in the lean group (β = 4.2 mm VAS, p = 0.03) but not in the group with obesity (p = 0.51). In the water-deprivation condition, higher Disinhibition was also associated with thirst in the lean group (β = 5.6 mm VAS, p = 0.01) with the strength of relationship being 3.5-fold stronger than that observed in the group with obesity (β = 1.6 mm VAS, p = 0.0003). Hunger, Restraint, and binge-eating scores were not associated with thirst in either dehydrating condition (all p > 0.05). Maladaptive eating behaviors were not associated with ad libitum water intake (all p > 0.05). Disinhibition is associated with higher thirst perception in healthy weight individuals and may be attenuated in obesity. The characteristics of disinhibition which typically includes a heightened readiness to eat, may reflect a more general phenotype that also reflects a readiness to drink.

Identifiants

pubmed: 36539161
pii: S0195-6663(22)00520-7
doi: 10.1016/j.appet.2022.106429
pmc: PMC9870948
mid: NIHMS1860890
pii:
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106429

Subventions

Organisme : Intramural NIH HHS
ID : Z99 DK999999
Pays : United States

Informations de copyright

Published by Elsevier Ltd.

Références

Am J Physiol. 1991 Mar;260(3 Pt 2):R475-9
pubmed: 1825748
Obes Res. 2002 Dec;10(12):1251-8
pubmed: 12490669
Front Physiol. 2021 Feb 10;12:632886
pubmed: 33679444
Am J Clin Nutr. 1991 Jun;53(6):1368-71
pubmed: 2035463
J Neurochem. 2000 Jan;74(1):34-41
pubmed: 10617103
Curr Biol. 2016 Dec 19;26(24):R1260-R1265
pubmed: 27997832
Appetite. 2015 Dec;95:166-75
pubmed: 26162949
Eur J Clin Nutr. 2010 Feb;64(2):115-23
pubmed: 19724292
Neuropeptides. 1990 Oct;17(2):107-10
pubmed: 2280821
Appetite. 1996 Feb;26(1):55-70
pubmed: 8660033
Science. 1982 Sep 24;217(4566):1214-22
pubmed: 7112124
Metabolism. 1977 Mar;26(3):309-17
pubmed: 319325
J Psychosom Res. 1985;29(1):71-83
pubmed: 3981480
Curr Obes Rep. 2019 Dec;8(4):363-372
pubmed: 31701348
Endocrinology. 2012 Mar;153(3):1411-20
pubmed: 22234465
Am J Physiol. 1991 Mar;260(3 Pt 2):R533-9
pubmed: 2001002
Science. 1968 Aug 23;161(3843):751-6
pubmed: 5663800
Curr Opin Psychol. 2017 Oct;17:106-112
pubmed: 28950955
J Clin Invest. 2007 Apr;117(4):1088-95
pubmed: 17404622
Front Psychol. 2016 May 23;7:743
pubmed: 27242642
J Nutr. 2013 Apr;143(4):479-85
pubmed: 23343677
Eur J Clin Nutr. 2020 Jan;74(1):158-166
pubmed: 31160665
Exp Physiol. 2022 Dec;107(12):1454-1466
pubmed: 36114682
Appetite. 1997 Feb;28(1):7-18
pubmed: 9134091
J Clin Invest. 2017 May 1;127(5):1932-1943
pubmed: 28414302
Int J Obes Relat Metab Disord. 2000 Dec;24(12):1715-25
pubmed: 11126230
Appetite. 2014 Jan;72:50-8
pubmed: 24096082
Homo. 2019 Nov 11;70(3):193-216
pubmed: 31593208
Obes Surg. 2016 Mar;26(3):631-9
pubmed: 26661107
Eat Behav. 2003 Nov;4(4):369-83
pubmed: 15000963
Obes Rev. 2008 Sep;9(5):409-19
pubmed: 18179615
Obes Rev. 2012 Feb;13(2):136-49
pubmed: 22034852
Appetite. 2015 Jan;84:34-42
pubmed: 25239401
J Clin Invest. 2017 May 1;127(5):1944-1959
pubmed: 28414295
Obesity (Silver Spring). 2015 Jun;23(6):1130-5
pubmed: 26010325
Int J Obes (Lond). 2021 Dec;45(12):2515-2526
pubmed: 34480102
Appetite. 2018 Jun 1;125:287-294
pubmed: 29309851
Clin Endocrinol (Oxf). 1987 Aug;27(2):253-8
pubmed: 3311483
Obesity (Silver Spring). 2022 Sep;30(9):1806-1817
pubmed: 35918877
Addict Behav. 1982;7(1):47-55
pubmed: 7080884
Clin Nutr. 2008 Oct;27(5):740-6
pubmed: 18774628
Circulation. 2004 Feb 10;109(5):594-600
pubmed: 14769680
Biochimie. 2016 May;124:84-91
pubmed: 26037452
Metabolism. 1990 Aug;39(8):783-6
pubmed: 2377076
J Exp Psychol Anim Learn Cogn. 2016 Oct;42(4):391-400
pubmed: 27732049
J Clin Chem Clin Biochem. 1986 May;24(5):277-82
pubmed: 3734698

Auteurs

Douglas C Chang (DC)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA. Electronic address: changdc@mail.nih.gov.

Emma J Stinson (EJ)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA.

Paolo Piaggi (P)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA; Department of Information Engineering, University of Pisa, Pisa, Italy.

Jonathan Krakoff (J)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA.

Marci E Gluck (ME)

Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH